Sriwatanakul K, McCormick K, Woolf P
J Clin Endocrinol Metab. 1984 Feb;58(2):255-61. doi: 10.1210/jcem-58-2-255.
A 12-yr-old girl with the syndrome of hyperthyroidism due to inappropriate TSH secretion, who had no evidence of pituitary tumor, was studied in detail. She had undergone two thyroidectomies for recurrent goiter and hyperthyroidism before referral. Basal serum TSH levels were extremely high (maximum 173 microU/ml), and the TSH response to TRH was exaggerated (peak, 675 microU/ml). The serum alpha-subunit of TSH was normal. PRL and other anterior pituitary hormone studies were normal. Dopamine infusion at 2 and 4 micrograms/kg X min partially suppressed TSH and PRL secretion and their responses to TRH. Bromocriptine had a paradoxical effect, resulting in an increase in TRH-stimulated TSH levels. Pergolide, a newer dopamine agonist, significantly decreased per basal serum TSH and blunted the TSH response to TRH; however, despite progressive dose increases, her TSH level was not reduced to normal.
一名12岁因不适当促甲状腺激素(TSH)分泌导致甲状腺功能亢进综合征的女孩,无垂体肿瘤证据,接受了详细研究。转诊前她因复发性甲状腺肿和甲状腺功能亢进接受了两次甲状腺切除术。基础血清TSH水平极高(最高达173微单位/毫升),TSH对促甲状腺激素释放激素(TRH)的反应增强(峰值为675微单位/毫升)。TSH的血清α亚基正常。催乳素(PRL)和其他垂体前叶激素检查正常。以2和4微克/千克×分钟的速度输注多巴胺可部分抑制TSH和PRL分泌及其对TRH的反应。溴隐亭产生了矛盾的效果,导致TRH刺激的TSH水平升高。培高利特,一种新型多巴胺激动剂,显著降低基础血清TSH水平并减弱TSH对TRH的反应;然而,尽管剂量逐渐增加,她的TSH水平仍未降至正常。